{
  "DOI": "10.1038/sj.ejhg.5201450",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/sj.ejhg.5201450",
  "alternative-id": [
    "BF5201450"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Moutel",
      "given": "Grégoire",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "the APROCO-COPILOTE Study Group",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Duchange",
      "given": "Nathalie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Raffi",
      "given": "François",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sharara",
      "given": "Lama I",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Théodorou",
      "given": "Ioannis",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Noël",
      "given": "Violaine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Montgolfier",
      "given": "Sandrine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Callies",
      "given": "Ingrid",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bricaire",
      "given": "François",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hervé",
      "given": "Christian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Leport",
      "given": "Catherine",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2005,
        6,
        15
      ]
    ],
    "date-time": "2005-06-15T11:04:16Z",
    "timestamp": 1118833456000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T01:34:20Z",
    "timestamp": 1684373660000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        5
      ]
    ],
    "date-time": "2024-02-05T05:23:44Z",
    "timestamp": 1707110624704
  },
  "is-referenced-by-count": 18,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2005,
        6,
        15
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2005,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2005,
            6,
            15
          ]
        ],
        "date-time": "2005-06-15T00:00:00Z",
        "timestamp": 1118793600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/5201450.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201450",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/5201450.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1055-1062",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2005,
        6,
        15
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2005,
        6,
        15
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/421557",
      "author": "E Quirk",
      "doi-asserted-by": "publisher",
      "first-page": "98",
      "journal-title": "Clin Infect Dis",
      "key": "BF5201450_CR1",
      "unstructured": "Quirk E, McLeod H, Powderly W : The pharmacogenetics of antiretroviral therapy: a review of studies to date. Clin Infect Dis 2004; 39: 98–106.",
      "volume": "39",
      "year": "2004"
    },
    {
      "DOI": "10.1024/0040-5930.61.10.613",
      "author": "A Telenti",
      "doi-asserted-by": "publisher",
      "first-page": "613",
      "journal-title": "Ther Umsch",
      "key": "BF5201450_CR2",
      "unstructured": "Telenti A, Furrer H : The genetics HIV cohort of the Swiss HIV Cohort Study – facing the new challenges in medicine. Ther Umsch 2004; 61: 613–618.",
      "volume": "61",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.micinf.2004.12.006",
      "author": "AP Galvani",
      "doi-asserted-by": "publisher",
      "first-page": "302",
      "journal-title": "Microbes Infect",
      "key": "BF5201450_CR3",
      "unstructured": "Galvani AP, Novembre J : The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes Infect 2005; 7: 302–309.",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1073/pnas.0307067101",
      "author": "AM Martin",
      "doi-asserted-by": "publisher",
      "first-page": "4180",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BF5201450_CR4",
      "unstructured": "Martin AM, Nolan D, Gaudieri S et al: Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci USA 2004; 101: 4180–4185.",
      "volume": "101",
      "year": "2004"
    },
    {
      "key": "BF5201450_CR5",
      "unstructured": "Nuffield Council on Bioethics: Pharmacogenetics. Ethical Issues 2003, \n                    http://www.nuffieldbioethics.org/\n                    \n                  ."
    },
    {
      "DOI": "10.1136/jme.2004.007229",
      "author": "OP Corrigan",
      "doi-asserted-by": "publisher",
      "first-page": "144",
      "journal-title": "J Med Ethics",
      "key": "BF5201450_CR6",
      "unstructured": "Corrigan OP : Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report. J Med Ethics 2005; 31: 144–148.",
      "volume": "31",
      "year": "2005"
    },
    {
      "key": "BF5201450_CR7",
      "unstructured": "RMGA: Statements of principles on the ethical conduct of human research involving population, 2003, \n                    http://www.rmga.qc.ca/\n                    \n                  ."
    },
    {
      "author": "I Callies",
      "first-page": "917",
      "journal-title": "Presse Med",
      "key": "BF5201450_CR8",
      "unstructured": "Callies I, Moutel G, Duchange N, Sharara L, Herve C : Communication of the results to those participating in biomedical research. New obligations and interrogations in France. Presse Med 2003; 32: 917–918.",
      "volume": "32",
      "year": "2003"
    },
    {
      "DOI": "10.2307/3564300",
      "author": "CV Fernandez",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "journal-title": "IRB",
      "key": "BF5201450_CR9",
      "unstructured": "Fernandez CV, Kodish E, Weijer C : Informing study participants of research results: an ethical imperative. IRB 2003; 25: 12–19.",
      "volume": "25",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0140-6736(02)09613-7",
      "author": "H Mann",
      "doi-asserted-by": "publisher",
      "first-page": "406",
      "journal-title": "Lancet",
      "key": "BF5201450_CR10",
      "unstructured": "Mann H : Research ethics committees and public dissemination of clinical trial results. Lancet 2002; 360: 406–408.",
      "volume": "360",
      "year": "2002"
    },
    {
      "DOI": "10.1001/jama.288.3.363",
      "author": "AH Partridge",
      "doi-asserted-by": "publisher",
      "first-page": "363",
      "journal-title": "JAMA",
      "key": "BF5201450_CR11",
      "unstructured": "Partridge AH, Winer EP : Informing clinical trial participants about study results. JAMA 2002; 288: 363–365.",
      "volume": "288",
      "year": "2002"
    },
    {
      "DOI": "10.1097/00008571-200212000-00001",
      "author": "S de Montgolfier",
      "doi-asserted-by": "publisher",
      "first-page": "667",
      "journal-title": "Pharmacogenetics",
      "key": "BF5201450_CR12",
      "unstructured": "de Montgolfier S, Moutel G, Duchange N, Theodorou I, Herve C, Leport C : Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients. Pharmacogenetics 2002; 12: 667–675.",
      "volume": "12",
      "year": "2002"
    },
    {
      "author": "A Clarke",
      "first-page": "89",
      "journal-title": "Int J Phamaceutical Med",
      "key": "BF5201450_CR13",
      "unstructured": "Clarke A, English V, Harris H, Wells F : Ethical considerations. Report of the Ethics Sub-group of the Pharmacogenetics Working Party, Society of Pharmaceutical Medicine. Int J Phamaceutical Med 2001; 15: 89–94.",
      "volume": "15",
      "year": "2001"
    },
    {
      "author": "O Ast",
      "first-page": "302",
      "journal-title": "Curr Opin Mol Ther",
      "key": "BF5201450_CR14",
      "unstructured": "Ast O, Luke W : Pharmacogenomics of HIV. Curr Opin Mol Ther 2004; 6: 302–307.",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1517/14622416.5.6.643",
      "author": "AM Martin",
      "doi-asserted-by": "publisher",
      "first-page": "643",
      "journal-title": "Pharmacogenomics",
      "key": "BF5201450_CR15",
      "unstructured": "Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S : Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Pharmacogenomics 2004; 5: 643–655.",
      "volume": "5",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0140-6736(03)12799-7",
      "author": "J Pich",
      "doi-asserted-by": "publisher",
      "first-page": "1015",
      "journal-title": "Lancet",
      "key": "BF5201450_CR16",
      "unstructured": "Pich J, Carne X, Arnaiz JA, Gomez B, Trilla A, Rodes J : Role of a research ethics committee in follow-up and publication of results. Lancet 2003; 361: 1015–1016.",
      "volume": "361",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0140-6736(03)12838-3",
      "author": "G Antes",
      "doi-asserted-by": "publisher",
      "first-page": "978",
      "journal-title": "Lancet",
      "key": "BF5201450_CR17",
      "unstructured": "Antes G, Chalmers I : Under-reporting of clinical trials is unethical. Lancet 2003; 361: 978–979.",
      "volume": "361",
      "year": "2003"
    },
    {
      "DOI": "10.1162/152651602317533596",
      "author": "PS Appelbaum",
      "doi-asserted-by": "publisher",
      "first-page": "22",
      "journal-title": "Am J Bioeth",
      "key": "BF5201450_CR18",
      "unstructured": "Appelbaum PS : Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception. Am J Bioeth 2002; 2: 22–23.",
      "volume": "2",
      "year": "2002"
    },
    {
      "DOI": "10.1097/00126334-200005010-00016",
      "author": "V Le Moing",
      "doi-asserted-by": "publisher",
      "first-page": "82",
      "journal-title": "J Acquir Immune Defic Syndr",
      "key": "BF5201450_CR19",
      "unstructured": "Le Moing V, Chene G, Masquelier B et al: Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. APROCO Study Group. J Acquir Immune Defic Syndr 2000; 24: 82–83.",
      "volume": "24",
      "year": "2000"
    },
    {
      "DOI": "10.1097/00002030-200112070-00012",
      "author": "S Duran",
      "doi-asserted-by": "publisher",
      "first-page": "2441",
      "journal-title": "Aids",
      "key": "BF5201450_CR20",
      "unstructured": "Duran S, Saves M, Spire B et al: Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. Aids 2001; 15: 2441–2444.",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1086/339866",
      "author": "M Saves",
      "doi-asserted-by": "publisher",
      "first-page": "1396",
      "journal-title": "Clin Infect Dis",
      "key": "BF5201450_CR21",
      "unstructured": "Saves M, Raffi F, Capeau J et al: Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2002; 34: 1396–1405.",
      "volume": "34",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0277-9536(01)00125-3",
      "author": "B Spire",
      "doi-asserted-by": "publisher",
      "first-page": "1481",
      "journal-title": "Soc Sci Med",
      "key": "BF5201450_CR22",
      "unstructured": "Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP : Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002; 54: 1481–1496.",
      "volume": "54",
      "year": "2002"
    },
    {
      "DOI": "10.1097/00002030-199711000-00001",
      "author": "L Meyer",
      "doi-asserted-by": "publisher",
      "first-page": "F73",
      "journal-title": "Aids",
      "key": "BF5201450_CR23",
      "unstructured": "Meyer L, Magierowska M, Hubert JB et al: Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. Aids 1997; 11: F73–78.",
      "volume": "11",
      "year": "1997"
    },
    {
      "DOI": "10.1126/science.273.5283.1856",
      "author": "M Dean",
      "doi-asserted-by": "publisher",
      "first-page": "1856",
      "journal-title": "Science",
      "key": "BF5201450_CR24",
      "unstructured": "Dean M, Carrington M, Winkler C et al: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856–1862.",
      "volume": "273",
      "year": "1996"
    },
    {
      "DOI": "10.1136/bmj.320.7240.987",
      "author": "CR Wolf",
      "doi-asserted-by": "publisher",
      "first-page": "987",
      "journal-title": "BMJ",
      "key": "BF5201450_CR25",
      "unstructured": "Wolf CR, Smith G, Smith RL : Science, medicine, and the future: pharmacogenetics. BMJ 2000; 320: 987–990.",
      "volume": "320",
      "year": "2000"
    },
    {
      "DOI": "10.1517/14622416.1.2.125",
      "author": "J Brockmoller",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "Pharmacogenomics",
      "key": "BF5201450_CR26",
      "unstructured": "Brockmoller J, Kirchheiner J, Meisel C, Roots I : Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment. Pharmacogenomics 2000; 1: 125–151.",
      "volume": "1",
      "year": "2000"
    },
    {
      "author": "A Clarke",
      "first-page": "89",
      "journal-title": "Int J Pharmaceutical Med",
      "key": "BF5201450_CR27",
      "unstructured": "Clarke A, English V, Harris H, wells F : Ethical considerations. Report of the Ethics Sub-group of the Pharmacogenetics Working Party, Society of Pharmaceutical Medicine. Int J Pharmaceutical Med 2001; 15: 89–94.",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1097/00043426-200309000-00006",
      "author": "CV Fernandez",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "journal-title": "J Pediatr Hematol Oncol",
      "key": "BF5201450_CR28",
      "unstructured": "Fernandez CV, Kodish E, Shurin S, Weijer C : Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group. J Pediatr Hematol Oncol 2003; 25: 704–708.",
      "volume": "25",
      "year": "2003"
    },
    {
      "key": "BF5201450_CR29",
      "unstructured": "NBAC: National Bioethics Advisory Commission: Report on research involving human biological materials: ethical issues and policy guidance, 1999, \n                    http://www.georgetown.edu/research/nrcbl/nbac/hbm.pdf\n                    \n                  ."
    },
    {
      "key": "BF5201450_CR30",
      "unstructured": "France: Law no 2002-303 of March 4, 2002 on the Rights of sick persons. JO Répub Franç no 54, 5 Mars 2002; p 4118 \n                    www.legifrance.gouv.fr\n                    \n                  ."
    },
    {
      "key": "BF5201450_CR31",
      "unstructured": "World Medical Association: Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects: Tokyo, 2004, \n                    http://www.wma.net/e/policy/b3.htm\n                    \n                  ."
    },
    {
      "key": "BF5201450_CR32",
      "unstructured": "France: Law No 88-1138 of December 20th, 1988 on the protection of persons accepting biomedical research (Huriet-Sérusclat Law) revised July 25th, 1994. Journal Officiel 26 juillet 1994; 10747–10749. \n                    www.legifrance.gouv.fr\n                    \n                  ."
    },
    {
      "key": "BF5201450_CR33",
      "unstructured": "France: Law no 2004-806 of August 9th 2004 on the new French public health politics. JO Répub Franç, August 11th 2004; 14277 \n                    www.legifrance.gouv.fr\n                    \n                  ."
    },
    {
      "DOI": "10.1002/ajmg.1568",
      "author": "AG Hunter",
      "doi-asserted-by": "publisher",
      "first-page": "265",
      "journal-title": "Am J Med Genet",
      "key": "BF5201450_CR34",
      "unstructured": "Hunter AG, Sharpe N, Mullen M, Meschino WS : Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics. Am J Med Genet 2001; 103: 265–276.",
      "volume": "103",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ajmg.1543",
      "author": "BM Knoppers",
      "doi-asserted-by": "publisher",
      "first-page": "277",
      "journal-title": "Am J Med Genet",
      "key": "BF5201450_CR35",
      "unstructured": "Knoppers BM : Duty to recontact: a legal harbinger? Am J Med Genet 2001; 103: 277.",
      "volume": "103",
      "year": "2001"
    },
    {
      "key": "BF5201450_CR36",
      "unstructured": "France: Code de déontologie médicale. Decree no 95-1000 of september 6th, 1995 modified by decree no 97-503 of may, 21th 1997; Available from: \n                    www.conseil-national.medecin.fr\n                    \n                  ."
    },
    {
      "DOI": "10.1056/NEJMsb030228",
      "author": "FG Miller",
      "doi-asserted-by": "publisher",
      "first-page": "1383",
      "journal-title": "N Engl J Med",
      "key": "BF5201450_CR37",
      "unstructured": "Miller FG, Rosenstein DL : The therapeutic orientation to clinical trials. N Engl J Med 2003; 348: 1383–1386.",
      "volume": "348",
      "year": "2003"
    },
    {
      "key": "BF5201450_CR38",
      "unstructured": "Cazé-de Montgolfier S : Collecte, stockage et utilisation des produits du corps humain dans le cadre de recherches en génétique : état des lieux historique, éthique et juridique. Analyse des pratiques au sein des biothèques. Thèse d'éthique médicale et biologique, Paris V, 2002, Available from: \n                    www.inserm.fr/ethique\n                    \n                  ."
    },
    {
      "DOI": "10.1038/sj.tpj.6500288",
      "author": "Y Joly",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Pharmacogenomics J",
      "key": "BF5201450_CR39",
      "unstructured": "Joly Y, Knoppers BM, Nguyen MT : Stored tissue samples: through the confidentiality maze. Pharmacogenomics J 2005; 5: 2–5.",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201037",
      "author": "C Julian-Reynier",
      "doi-asserted-by": "publisher",
      "first-page": "725",
      "journal-title": "Eur J Hum Genet",
      "key": "BF5201450_CR40",
      "unstructured": "Julian-Reynier C, Welkenhuysen M, Hagoel L, Decruyenaere M, Hopwood P : Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services. Eur J Hum Genet 2003; 11: 725–736.",
      "volume": "11",
      "year": "2003"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/5201450"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients"
  ],
  "type": "journal-article",
  "volume": "13"
}